ELOVL2 and meningioma: Recent in vitro analyses revealed a dose-dependent efficiency of DCT also in high-grade meningiomas, with specific DNA demethylation of several onco- or tumor suppressor genes (TRIM58, FAM84B, ELOVL2, MAL2, LMO3, DIO3), which have been hardly investigated in meningiomas yet [33].